Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AECOMACM · Entity 3602 | Director | March 06, 2020 | March 10, 2020 |
| Accolade, Inc.ACCD · Entity 80959 | Director | June 16, 2021 | June 21, 2021 |
| Mirion Technologies, Inc.GSAH · Entity 394 | Director | August 13, 2020 | August 15, 2020 |
| SmileDirectClub, Inc.SDC · Entity 111962 | Director | May 12, 2021 | May 14, 2021 |
| Teladoc Health, Inc.TDOC · Entity 1547 | Director | May 26, 2022 | May 31, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AECOM
Report date March 06, 2020 · Filed March 10, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 51,603 |
Reported balance
After 2020-03-06 transaction · row 1
1 source rowRow 1 · 2020-03-06 · Exercise / conversion · Acquired 5,245 · Balance 51,603 F1: Each restricted stock unit represented a contingent right to receive one share of AECOM common stock. On March 6, 2020, 5,245 of the reporting person restricted stock units vested and were settled for an equal number of shares of AECOM common stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-03-06 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-03-06 · Exercise / conversion · Disposed 5,245 · Balance 0 F1: Each restricted stock unit represented a contingent right to receive one share of AECOM common stock. On March 6, 2020, 5,245 of the reporting person restricted stock units vested and were settled for an equal number of shares of AECOM common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represented a contingent right to receive one share of AECOM common stock. On March 6, 2020, 5,245 of the reporting person restricted stock units vested and were settled for an equal number of shares of AECOM common stock.
Accolade, Inc.
Report date June 16, 2021 · Filed June 21, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 302,895 |
Ending reported balance
After 2021-06-16 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2021-06-16 · Exercise / conversion · Acquired 250 · Balance 302,229 Row 2 · 2021-06-16 · Exercise / conversion · Acquired 250 · Balance 302,479 Row 3 · 2021-06-16 · Exercise / conversion · Acquired 416 · Balance 302,895 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.50 · Expires 2027-07-26 | Direct | 500 |
Reported balance
After 2021-06-16 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-06-16 · Exercise / conversion · Disposed 250 · Balance 500 F1: The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of July 26, 2017 (the "July 2017 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the July 2017 Vesting Commencement Date thereafter for so long as the Reporting Person remains an employee or consultant of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the July 2017 Vesting Commencement Date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.70 · Expires 2028-05-02 | Direct | 2,750 |
Reported balance
After 2021-06-16 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-06-16 · Exercise / conversion · Disposed 250 · Balance 2,750 F2: The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of May 3, 2018 (the "May 2018 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the May 2018 Vesting Commencement Date thereafter for so long as the Reporting Person remains an employee or consultant of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the May 2018 Vesting Commencement Date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.70 · Expires 2028-07-25 | Direct | 5,834 |
Reported balance
After 2021-06-16 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2021-06-16 · Exercise / conversion · Disposed 416 · Balance 5,834 F3: The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of July 26, 2018 (the "July 2018 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the July 2018 Vesting Commencement Date thereafter for so long as the Reporting Person remains an employee or consultant of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the July 2018 Vesting Commencement Date. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of July 26, 2017 (the "July 2017 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the July 2017 Vesting Commencement Date thereafter for so long as the Reporting Person remains an employee or consultant of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the July 2017 Vesting Commencement Date.
F2: The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of May 3, 2018 (the "May 2018 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the May 2018 Vesting Commencement Date thereafter for so long as the Reporting Person remains an employee or consultant of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the May 2018 Vesting Commencement Date.
F3: The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of July 26, 2018 (the "July 2018 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the July 2018 Vesting Commencement Date thereafter for so long as the Reporting Person remains an employee or consultant of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the July 2018 Vesting Commencement Date.
Mirion Technologies, Inc.
Report date August 13, 2020 · Filed August 15, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Sponsor LLC InterestSEC Table II · derivative / convertible security | Direct | 35,000 |
Reported balance
After 2020-08-13 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-08-13 · Other · Acquired 35,000 · Balance 35,000 F1: This Form 4 is being filed to report the issuance of certain GS Sponosr II LLC (the "Sponsor") limited liability interests (the "Sponsor LLC Interests"), which have been issued to certain individuals associated with GS Acquisition Holdings Corp II (the "Issuer"). The Sponsor LLC Interests entitle the reporting person to certain economic interests with respect to 35,000 shares of Class B common stock, par value $0.0001 per share, of the Issuer held by the Sponsor |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4 is being filed to report the issuance of certain GS Sponosr II LLC (the "Sponsor") limited liability interests (the "Sponsor LLC Interests"), which have been issued to certain individuals associated with GS Acquisition Holdings Corp II (the "Issuer"). The Sponsor LLC Interests entitle the reporting person to certain economic interests with respect to 35,000 shares of Class B common stock, par value $0.0001 per share, of the Issuer held by the Sponsor
SmileDirectClub, Inc.
Report date May 12, 2021 · Filed May 14, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 64,241 |
Reported balance
After 2021-05-12 transaction · row 1
1 source rowRow 1 · 2021-05-12 · Purchase · Acquired 13,000 · Balance 64,241 |
Teladoc Health, Inc.
Report date May 26, 2022 · Filed May 31, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 6,726 |
Reported balance
After 2022-05-26 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-05-26 · Grant · Acquired 6,726 · Balance 6,726 F1: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2: The restricted stock units vest in full on the earlier of (i) May 26, 2023 and (ii) the day immediately preceding the issuer's 2023 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F2: The restricted stock units vest in full on the earlier of (i) May 26, 2023 and (ii) the day immediately preceding the issuer's 2023 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
SELECT MEDICAL HOLDINGS CORP
Report date June 30, 2026 · Filed July 01, 2026
Section 16 reporting ended · disclosed 2026-07-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-06-30 transaction · row 1
1 source rowRow 1 · 2026-06-30 · Disposition to issuer · Disposed 306,266 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation, and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026). At the effective time of the merger, each of the Reporting Person's shares of common stock issued and outstanding immediately prior to the effective time of the merger was converted into the right to receive $16.50 per share in cash without interest ("Merger Consideration"). F2: Includes unvested shares of Company common stock subject to forfeiture conditions (the "Company Restricted Shares"). Pursuant the Merger Agreement, each Company Restricted Share held by the Reporting Person that was outstanding immediately prior to the effective time vested in full as of immediately prior to the effective time of the merger and was automatically converted into the right to receive the Merger Consideration, less any applicable tax withholdings. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation, and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026). At the effective time of the merger, each of the Reporting Person's shares of common stock issued and outstanding immediately prior to the effective time of the merger was converted into the right to receive $16.50 per share in cash without interest ("Merger Consideration").
F2: Includes unvested shares of Company common stock subject to forfeiture conditions (the "Company Restricted Shares"). Pursuant the Merger Agreement, each Company Restricted Share held by the Reporting Person that was outstanding immediately prior to the effective time vested in full as of immediately prior to the effective time of the merger and was automatically converted into the right to receive the Merger Consideration, less any applicable tax withholdings.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 31, 2018 Filed Aug 2, 2018 21:10 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 865 | $20.80 | $17,992.00 |
DisclosureSEC source: 0001179110-18-010158 · edgar.xml · nonDerivative · entry 2 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,374 F2 · shares: This grant of restricted stock was issued pursuant to the Select Medical Holdings Corporation 2016 Equity Incentive Plan in lieu of a quarterly retainer of $18,000. Read SEC document |
| July 31, 2018 Filed Aug 2, 2018 21:10 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-010158 · edgar.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,509 F1 · shares: Grant of restricted stock which, subject to certain exceptions, will vest in full on July 31, 2019, the first anniversary of the grant date. Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 21:35 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 1,965 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-007974 · edgar.xml · derivative · entry 2 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,965 Underlying: Common Stock · 1,965 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F1 · derivative.exercise_date: The restricted stock units vest in full on the earlier of (i) May 31, 2019 and (ii) the day immediately preceding the issuer's 2019 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. F1 · derivative.expiration_date: The restricted stock units vest in full on the earlier of (i) May 31, 2019 and (ii) the day immediately preceding the issuer's 2019 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 21:35 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantStock Option (right to buy) · Derivative | 4,082 | $0.00 Strike: $50.90 | $0.00 |
DisclosureSEC source: 0001179110-18-007974 · edgar.xml · derivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,082 Underlying: Common Stock · 4,082 shares Expires 2028-05-31 F2 · derivative.exercise_date: The option vests in full on the earlier of (i) May 31, 2019 and (ii) the day immediately preceding the issuer's 2019 annual meeting of stockholders. Read SEC document |
| May 25, 2018 Filed May 30, 2018 20:55 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 918 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-007677 · edgar.xml · derivative · entry 2 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 918 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: On May 25, 2017, the reporting person was granted 918 restricted stock units, vesting in full on May 25, 2018. F2 · derivative.expiration_date: On May 25, 2017, the reporting person was granted 918 restricted stock units, vesting in full on May 25, 2018. Read SEC document |
| May 25, 2018 Filed May 30, 2018 20:55 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 918 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-18-007677 · edgar.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,418 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| May 01, 2018 Filed May 2, 2018 21:29 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 994 | $18.10 | $17,991.40 |
DisclosureSEC source: 0001179110-18-006065 · edgar.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,509 F1 · shares: This grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2016 Equity Incentive Plan in lieu of a quarterly retainer of $18,000. Read SEC document |
| February 28, 2018 Filed Mar 3, 2018 00:47 UTC | AECOM ACM · Entity 3602 | GrantRestricted Stock Units · Derivative | 4,506 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-003377 · edgar.xml · derivative · entry 3 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,506 Underlying: Common Stock · 4,506 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of AECOM common stock. F3 · derivative.exercise_date: The restricted stock units vest on the earlier of February 28, 2019 or the date of the Corporation's 2019 Annual Meeting of Stockholders. F3 · derivative.expiration_date: The restricted stock units vest on the earlier of February 28, 2019 or the date of the Corporation's 2019 Annual Meeting of Stockholders. Read SEC document |
| February 28, 2018 Filed Mar 3, 2018 00:47 UTC | AECOM ACM · Entity 3602 | Exercise / conversionRestricted Stock Units · Derivative | 4,229 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-003377 · edgar.xml · derivative · entry 2 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,229 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represented a contingent right to receive one share of AECOM common stock. On February 28, 2018, 4,229 of the reporting person restricted stock units vested and were settled for an equal number of shares of AECOM common stock. F1 · derivative.exercise_date: Each restricted stock unit represented a contingent right to receive one share of AECOM common stock. On February 28, 2018, 4,229 of the reporting person restricted stock units vested and were settled for an equal number of shares of AECOM common stock. F1 · derivative.expiration_date: Each restricted stock unit represented a contingent right to receive one share of AECOM common stock. On February 28, 2018, 4,229 of the reporting person restricted stock units vested and were settled for an equal number of shares of AECOM common stock. Read SEC document |
| February 28, 2018 Filed Mar 3, 2018 00:47 UTC | AECOM ACM · Entity 3602 | Exercise / conversionCommon Stock | 4,229 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-18-003377 · edgar.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,852 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represented a contingent right to receive one share of AECOM common stock. On February 28, 2018, 4,229 of the reporting person restricted stock units vested and were settled for an equal number of shares of AECOM common stock. Read SEC document |
| February 14, 2018 Filed Feb 16, 2018 01:15 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 1,088 | $16.55 | $18,006.40 |
DisclosureSEC source: 0001179110-18-002213 · edgar.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,515 F1 · shares: This grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2016 Equity Incentive Plan in lieu of a quarterly retainer of $18,000. Read SEC document |
| November 01, 2017 Filed Nov 3, 2017 20:07 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 968 | $18.60 | $18,004.80 |
DisclosureSEC source: 0001179110-17-013717 · edgar.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,427 F1 · shares: This grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2016 Equity Incentive Plan in lieu of a quarterly retainer of $18,000. Read SEC document |
| August 02, 2017 Filed Aug 4, 2017 20:50 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 1,139 | $15.80 | $17,996.20 |
DisclosureSEC source: 0001179110-17-011142 · edgar.xml · nonDerivative · entry 2 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,459 F2 · shares: This grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2016 Equity Incentive Plan in lieu of a quarterly retainer of $18,000. Read SEC document |
| August 02, 2017 Filed Aug 4, 2017 20:50 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-011142 · edgar.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,320 F1 · shares: Grant of restricted stock which, subject to certain exceptions, will vest in full on August 2, 2018, the first anniversary of the grant date. Read SEC document |
| May 25, 2017 Filed May 31, 2017 00:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 918 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-008231 · edgar.xml · derivative · entry 2 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 918 Underlying: Common Stock · 918 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F3 · derivative.exercise_date: The restricted stock units vest in full on the earlier of (i) May 25, 2018 and (ii) the day immediately preceding the issuer's 2018 annual meeting of stockholders. F3 · derivative.expiration_date: The restricted stock units vest in full on the earlier of (i) May 25, 2018 and (ii) the day immediately preceding the issuer's 2018 annual meeting of stockholders. Read SEC document |
| May 25, 2017 Filed May 31, 2017 00:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantStock Option (right to buy) · Derivative | 7,689 | $0.00 Strike: $30.50 | $0.00 |
DisclosureSEC source: 0001179110-17-008231 · edgar.xml · derivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,689 Underlying: Common Stock · 7,689 shares Expires 2027-05-25 F1 · derivative.exercise_date: The option vests in full on the earlier of (i) May 25, 2018 and (ii) the day immediately preceding the issuer's 2018 annual meeting of stockholders. Read SEC document |
| May 03, 2017 Filed May 4, 2017 22:10 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 1,319 | $13.65 | $18,004.35 |
DisclosureSEC source: 0001179110-17-006594 · edgar.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,320 F1 · shares: This grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2016 Equity Incentive Plan in lieu of a quarterly retainer of $18,000. Read SEC document |
| March 01, 2017 Filed Mar 4, 2017 00:52 UTC | AECOM ACM · Entity 3602 | GrantRestricted Stock Units · Derivative | 4,229 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-003908 · edgar.xml · derivative · entry 3 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,229 Underlying: Common Stock · 4,229 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of AECOM common stock. F3 · derivative.exercise_date: The restricted stock units vest on the earlier of March 1, 2018 or the date of the Corporation's 2018 Annual Meeting of Stockholders. F3 · derivative.expiration_date: The restricted stock units vest on the earlier of March 1, 2018 or the date of the Corporation's 2018 Annual Meeting of Stockholders. Read SEC document |
| March 01, 2017 Filed Mar 4, 2017 00:52 UTC | AECOM ACM · Entity 3602 | Exercise / conversionRestricted Stock Units · Derivative | 4,836 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-003908 · edgar.xml · derivative · entry 2 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,836 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represented a contingent right to receive one share of AECOM common stock. On March 1, 2017, 4,836 of the reporting person restricted stock units vested and were settled for an equal number of shares of AECOM common stock. F1 · derivative.exercise_date: Each restricted stock unit represented a contingent right to receive one share of AECOM common stock. On March 1, 2017, 4,836 of the reporting person restricted stock units vested and were settled for an equal number of shares of AECOM common stock. F1 · derivative.expiration_date: Each restricted stock unit represented a contingent right to receive one share of AECOM common stock. On March 1, 2017, 4,836 of the reporting person restricted stock units vested and were settled for an equal number of shares of AECOM common stock. Read SEC document |
| March 01, 2017 Filed Mar 4, 2017 00:52 UTC | AECOM ACM · Entity 3602 | Exercise / conversionCommon Stock | 4,836 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-17-003908 · edgar.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,623 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represented a contingent right to receive one share of AECOM common stock. On March 1, 2017, 4,836 of the reporting person restricted stock units vested and were settled for an equal number of shares of AECOM common stock. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 21:48 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 1,401 | $12.85 | $18,002.85 |
DisclosureSEC source: 0001179110-17-002671 · edgar.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,001 F1 · shares: This grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2016 Equity Incentive Plan in lieu of a quarterly retainer of $18,000. Read SEC document |
| November 02, 2016 Filed Nov 3, 2016 20:53 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 1,475 | $12.20 | $17,995.00 |
DisclosureSEC source: 0001179110-16-031160 · edgar.xml · nonDerivative · entry 1 Frist William H. · CIK 0001477553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,600 F1 · shares: This grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2016 Equity Incentive Plan in lieu of a quarterly retainer of $18,000. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.